Our Research
Research Themes | Distinctive Strengths | Scope | Benefits
Research Themes & Foci
- Breaking new ground for cancer diagnostics and therapeutics:
- Driving translation of new individualised therapies
- Exploiting new breakthroughs in physics and chemistry
- Discovering new molecular pathways in cancer
- Overcoming hurdles to cancer therapy:
- Individualising cancer therapies
- Predicting and treating resistance to therapies
- Improving the patient journey:
- Optimising symptom control
- Reducing treatment side effects
Distinctive Strengths
The Centre’s researchers have world-leading strengths in blood cancers and solid tumours, particularly breast, lung, sarcomas and melanoma and treatments for symptom control.
Clinical research and training is a particular strength with over 80% of the state's cancer treatments delivered by The University of Adelaide’s clinical researchers and affiliates at South Australia’s teaching hospitals.
The Centre's broader vision is to develop new collaborative research programs based on these unique strengths, involving novel and innovative approaches to cancer research and clinical application.
Scope
The Centre's research involves personalised cancer medicine through the complete patient journey from prevention through to treatment approaches, survival, rehabilitation and palliative care, providing:
- development of personalised cancer diagnostics and therapeutics using tumour profiling, and cellular and animal models
- provision of the basis for personalised cancer medicine by integrating the diagnostic and therapeutic tools with pharmacokinetics and pharmacogenomics
- evaluation and translation of personalised cancer medicine through the development and participation in pre-clinical and clinical trials.
Benefits
Outcomes of the Centre's reseach will include:
- higher levels of cancer research funding
- high quality research publications
- development and commercialisation of new cancer diagnostic approaches and therapeutics
- a new generation of trained translational and clinical researchers
- demonstrate personalised cancer medicine can improve clinical outcomes and survival rates of cancer patients by increasing the effectiveness of existing and new molecular based therapies
- implementing personalised cancer care within the clinical setting.
